Herrmann, Howard C.

Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery

Leon, M. B., Smith, C. R., Mack, M., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2010) · New England Journal of Medicine

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 7,205

Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients

Smith, C. R., Leon, M. B., Mack, M. J., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2011) · New England Journal of Medicine

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 6,345

5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial

Mack, M. J., Leon, M. B., Smith, C. R., Miller, D. C., Moses, J. W., Tuzcu, E. M., Webb, J. G., Douglas, P. S., Anderson, W. N., Blackstone, E. H., et al. (2015) · The Lancet

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 1,739

5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial

Kapadia, S. R., Leon, M. B., Makkar, R. R., Tuzcu, E. M., Svensson, L. G., Kodali, S., Webb, J. G., Mack, M. J., Douglas, P. S., Thourani, V. H., et al. (2015) · The Lancet

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 867

Predictors of Mortality and Outcomes of Therapy in Low-Flow Severe Aortic Stenosis: A Placement of Aortic Transcatheter Valves (PARTNER) Trial Analysis

Herrmann, H. C., Pibarot, P., Hueter, I., Gertz, Z. M., Stewart, W. J., Kapadia, S., Tuzcu, E. M., Babaliaros, V., Thourani, V., Szeto, W. Y., et al. (2013) · Circulation

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 433

Health-Related Quality of Life After Transcatheter Aortic Valve Replacement in Inoperable Patients With Severe Aortic Stenosis

Reynolds, M. R., Magnuson, E. A., Lei, Y., Leon, M. B., Smith, C. R., Svensson, L. G., Webb, J. G., Babaliaros, V. C., Bowers, B. S., Fearon, W. F., et al. (2011) · Circulation

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 318

Hormonal control of angiotensinogen production

Dzau, V. J., & Herrmann, H. C. (1982) · Life Sciences

Renin-Angiotensin System StudiesCoagulation, Bradykinin, Polyphosphates, and Angioedema

Cited by 98

Comprehensive Analysis of Mortality Among Patients Undergoing TAVR

Svensson, L. G., Blackstone, E. H., Rajeswaran, J., Brozzi, N., Leon, M. B., Smith, C. R., Mack, M., Miller, D. C., Moses, J. W., Tuzcu, E. M., et al. (2014) · Journal of the American College of Cardiology

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 88

Stratification of Outcomes After Transcatheter Aortic Valve Replacement According to Surgical Inoperability for Technical Versus Clinical Reasons

Makkar, R. R., Jilaihawi, H., Mack, M., Chakravarty, T., Cohen, D. J., Cheng, W., Fontana, G. P., Bavaria, J. E., Thourani, V. H., Herrmann, H. C., et al. (2014) · Journal of the American College of Cardiology

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 70